About Enhancer

Enhancer ID: E_01_0569
Species: human
Position : chrX:15492185-15494185
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: The novel coronavirus
Pubmed ID:  32511315
Enhancer experiment: ChIP-seq?RNA-seq
Enhancer experiment description: The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons.

About Target gene

Target gene : ACE2
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons.

About TF

TF name : --
TF experiment: ChIP-seq?RNA-seq
TF experiment description: The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons.

About Function

Enhancer function : The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
The ACE2 gene is expressed in SARS-CoV-2 target cells, including Type II Pneumocytes (Ziegler, 2020), and is activated by interferons.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs